Sage Therapeutics Inc. (SAGE)
NASDAQ: SAGE
· Real-Time Price · USD
9.23
-0.05 (-0.54%)
At close: Jun 27, 2025, 2:32 PM
Sage Therapeutics Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 |
|---|---|---|---|---|---|---|
| Collaboration Revenue Related Party Revenue | 36.09M | 824K | 7.69M | 6.31M | 6.7M | 3.96M |
| Collaboration Revenue Related Party Revenue Growth | +4279.49% | -89.28% | +21.85% | -5.85% | +69.32% | n/a |
| Other Collaboration Revenue Revenue | 1.58M | 177K | n/a | n/a | n/a | n/a |
| Other Collaboration Revenue Revenue Growth | +793.79% | n/a | n/a | n/a | n/a | n/a |
| Product Revenue | 3.57M | 10.45M | n/a | n/a | n/a | n/a |
| Product Revenue Growth | -65.81% | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 57.59M | 54.65M | 53.22M | 55.98M | 51.98M | 55.11M | 78.14M | 75.56M | 65.71M | 67.33M | 61.48M | 52.41M | 46.48M | 51.6M | 48.71M | 43.35M | 39.85M | 53.5M | 35.1M | 38.22M | 70.13M | 85.13M | 88.5M | 88.23M | 83.92M | 75.69M | 53.69M | 43.17M | 28.85M | 19.56M | 16.09M | 14.95M | 12.28M | 14.38M | 8.99M | 8.91M | 7.13M | 8.24M | 6.6M | 6.46M | 4M |
| Selling, General, and Administrative Revenue Growth | +5.39% | +2.68% | -4.94% | +7.71% | -5.68% | -29.48% | +3.41% | +15.00% | -2.41% | +9.51% | +17.31% | +12.77% | -9.93% | +5.94% | +12.37% | +8.78% | -25.52% | +52.42% | -8.18% | -45.50% | -17.62% | -3.81% | +0.31% | +5.13% | +10.86% | +40.98% | +24.38% | +49.63% | +47.50% | +21.58% | +7.58% | +21.78% | -14.57% | +59.92% | +0.89% | +24.91% | -13.39% | +24.71% | +2.29% | +61.52% | n/a |
| Research and Development Revenue | 22.76M | 37.02M | 54.58M | 62.56M | 71.73M | 64.33M | 101.92M | 97.16M | 92.83M | 89.3M | 81.55M | 77.3M | 78.02M | 75.44M | 83.5M | 66.17M | 58.06M | 81.71M | 74.08M | 73.32M | 63.61M | 91.25M | 102.11M | 89.06M | 86.4M | 88.81M | 75.05M | 68.98M | 49.27M | 50.89M | 58.29M | 55.9M | 45.2M | 42M | 29.07M | 26.1M | 23.58M | 20.38M | 17.48M | 18.6M | 12.9M |
| Research and Development Revenue Growth | -38.52% | -32.17% | -12.77% | -12.78% | +11.51% | -36.88% | +4.90% | +4.67% | +3.95% | +9.49% | +5.51% | -0.92% | +3.41% | -9.65% | +26.19% | +13.98% | -28.95% | +10.30% | +1.03% | +15.26% | -30.29% | -10.63% | +14.65% | +3.08% | -2.71% | +18.32% | +8.80% | +40.00% | -3.18% | -12.69% | +4.27% | +23.67% | +7.61% | +44.47% | +11.42% | +10.67% | +15.73% | +16.58% | -6.05% | +44.21% | n/a |